logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 7
  • 1
    Amerson, Dave
    Born in December 1962
    Individual (1 offspring)
    Officer
    icon of calendar 2025-04-15 ~ now
    OF - Director → CIF 0
  • 2
    Chu, Yen-min Kevin
    Born in February 1989
    Individual (1 offspring)
    Officer
    icon of calendar 2024-05-23 ~ now
    OF - Director → CIF 0
  • 3
    Chamas, Liliane, Doctor
    Born in October 1986
    Individual (4 offsprings)
    Officer
    icon of calendar 2021-06-18 ~ now
    OF - Director → CIF 0
  • 4
    Le, Tiffany
    Born in June 1990
    Individual (1 offspring)
    Officer
    icon of calendar 2024-05-23 ~ now
    OF - Director → CIF 0
  • 5
    Crawley, Aidan Harold Winston
    Born in October 1983
    Individual (5 offsprings)
    Officer
    icon of calendar 2020-12-18 ~ now
    OF - Director → CIF 0
  • 6
    Butler, Caroline
    Born in February 1980
    Individual (1 offspring)
    Officer
    icon of calendar 2024-05-23 ~ now
    OF - Director → CIF 0
  • 7
    OXFORD SCIENCES INNOVATION PLC - 2021-09-30
    OXFORD SCIENCES PLC - 2015-03-17
    icon of address46, Woodstock Road, Oxford, United Kingdom
    Active Corporate (11 parents, 58 offsprings)
    Person with significant control
    icon of calendar 2024-05-23 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Ceased 3
  • 1
    Glenn, Jonathan Martin
    Non-Executive Director born in November 1968
    Individual (2 offsprings)
    Officer
    icon of calendar 2023-12-01 ~ 2024-04-30
    OF - Director → CIF 0
  • 2
    Aidan Harold Winston Crawley
    Born in October 1983
    Individual (5 offsprings)
    Person with significant control
    icon of calendar 2020-12-18 ~ 2021-06-18
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
  • 3
    Denison, Tim
    Professor Of Engineering Science born in July 1970
    Individual (2 offsprings)
    Officer
    icon of calendar 2021-06-18 ~ 2024-05-23
    OF - Director → CIF 0
parent relation
Company in focus

AMBER THERAPEUTICS HOLDINGS LIMITED

Previous name
AMBER THERAPEUTICS LTD - 2024-07-11
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
02024-01-01 ~ 2024-12-31
62023-01-01 ~ 2023-12-31
Property, Plant & Equipment
11,380 GBP2023-12-31
Fixed Assets - Investments
3,750,578 GBP2024-12-31
3,273,578 GBP2023-12-31
Fixed Assets
3,750,578 GBP2024-12-31
3,284,958 GBP2023-12-31
Debtors
Current
17,293,015 GBP2024-12-31
617,857 GBP2023-12-31
Cash at bank and in hand
164,652 GBP2024-12-31
2,295,352 GBP2023-12-31
Current Assets
17,457,667 GBP2024-12-31
2,913,209 GBP2023-12-31
Net Current Assets/Liabilities
17,456,429 GBP2024-12-31
-4,306,365 GBP2023-12-31
Total Assets Less Current Liabilities
21,207,007 GBP2024-12-31
-1,021,407 GBP2023-12-31
Creditors
Non-current, Amounts falling due after one year
-732,009 GBP2023-12-31
Net Assets/Liabilities
21,207,007 GBP2024-12-31
-1,753,416 GBP2023-12-31
Equity
Called up share capital
8,588 GBP2024-12-31
1,303 GBP2023-12-31
1,303 GBP2023-01-01
Share premium
26,612,036 GBP2024-12-31
999,696 GBP2023-12-31
999,696 GBP2023-01-01
Retained earnings (accumulated losses)
-5,413,617 GBP2024-12-31
-2,754,415 GBP2023-12-31
-766,047 GBP2023-01-01
Equity
21,207,007 GBP2024-12-31
-1,753,416 GBP2023-12-31
234,952 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
-2,659,202 GBP2024-01-01 ~ 2024-12-31
-1,988,368 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-2,659,202 GBP2024-01-01 ~ 2024-12-31
-1,988,368 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-2,659,202 GBP2024-01-01 ~ 2024-12-31
Comprehensive Income/Expense
-2,659,202 GBP2024-01-01 ~ 2024-12-31
Issue of Equity Instruments
Called up share capital
7,285 GBP2024-01-01 ~ 2024-12-31
Issue of Equity Instruments
25,619,625 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
102024-01-01 ~ 2024-12-31
Office equipment
332024-01-01 ~ 2024-12-31
Computers
332024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Gross Cost
Computers
17,324 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Computers
5,944 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers, Owned/Freehold
4,843 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Computers
11,380 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
17,053,575 GBP2024-12-31
441,180 GBP2023-12-31
Other Debtors
Current
240,249 GBP2024-12-31
152,738 GBP2023-12-31
Prepayments/Accrued Income
Current
-809 GBP2024-12-31
23,939 GBP2023-12-31
Bank Overdrafts
-1,238 GBP2024-12-31
-26,615 GBP2023-12-31
Cash and Cash Equivalents
163,414 GBP2024-12-31
2,268,737 GBP2023-12-31
Bank Overdrafts
Current
1,238 GBP2024-12-31
26,615 GBP2023-12-31
Other Remaining Borrowings
Current
6,873,385 GBP2023-12-31
Trade Creditors/Trade Payables
Current
227,315 GBP2023-12-31
Taxation/Social Security Payable
Current
19,249 GBP2023-12-31
Other Creditors
Current
3,188 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
69,822 GBP2023-12-31
Creditors
Current
1,238 GBP2024-12-31
7,219,574 GBP2023-12-31
Other Creditors
Non-current
732,009 GBP2023-12-31
Creditors
Non-current
732,009 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,047,066 shares2024-12-31
1,000,000 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.0012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
303,030 shares2024-12-31
303,030 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0.0012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
4,980,000 shares2024-12-31
Par Value of Share
Class 3 ordinary share
0.0012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
2,257,853 shares2024-12-31
Par Value of Share
Class 4 ordinary share
0.0012024-01-01 ~ 2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
34,090 GBP2023-12-31
Between one and five year
32,812 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
66,902 GBP2023-12-31
Related profiles found in government register
  • AMBER THERAPEUTICS HOLDINGS LIMITED
    Info
    AMBER THERAPEUTICS LTD - 2024-07-11
    Registered number 13089338
    icon of addressUnit 1 Tech Foundry 2, Curie Avenue, Didcot OX11 0QQ
    PRIVATE LIMITED COMPANY incorporated on 2020-12-18 (5 years). The company status is Active.
    The last date of confirmation statement was made at 2024-12-17
    CIF 0
  • AMBER THERAPEUTICS HOLDINGS LIMITED
    S
    Registered number 13089338
    icon of addressCannon Place, 78 Cannon Street, Cannon Place, 78 Cannon Street, London, England, EC4N 6AF
    Limited Company in Uk, United Kingdom
    CIF 1
  • AMBER THERAPEUTICS HOLDINGS LIMITED
    S
    Registered number 13089338
    icon of addressUnit 1, Tech Foundry 2, Curie Avenue, Didcot, England, OX11 0QQ
    Company Limited By Shares in United Kingdom
    CIF 2
  • AMBER THERAPEUTICS LTD
    S
    Registered number 13089338
    icon of address42, Sutherland Place, London, England, W2 5BY
    Company Limited By Shares in United Kingdom
    CIF 3
(more)
child relation
Offspring entities and appointments
Active 3
  • 1
    FINETECH MEDICAL LIMITED - 2024-07-11
    icon of addressUnit 1 Tech Foundry 2, Curie Avenue, Didcot, England
    Active Corporate (2 parents)
    Profit/Loss (Company account)
    -4,564,824 GBP2024-01-01 ~ 2024-12-31
    Person with significant control
    icon of calendar 2024-07-22 ~ now
    CIF 2 - Right to appoint or remove directors → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Ownership of shares – 75% or more → OE
  • 2
    icon of addressJames Cowper Kreston The White Building, 1-4 Cumberland Place, Southampton
    Liquidation Corporate (3 parents, 1 offspring)
    Equity (Company account)
    143,872 GBP2023-12-31
    Person with significant control
    icon of calendar 2023-07-25 ~ now
    CIF 3 - Ownership of shares – 75% or more → OE
    CIF 3 - Ownership of voting rights - 75% or more → OE
    CIF 3 - Right to appoint or remove directors → OE
    icon of calendar 2024-07-11 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
  • 3
    FINETECH NEUROMODULATION LIMITED - 2014-10-09
    icon of addressC/o James Cowper Kreston The White Building, 1-4 Cumberland Place, Southampton
    Liquidation Corporate (4 parents)
    Person with significant control
    icon of calendar 2023-07-25 ~ now
    CIF 4 - Ownership of voting rights - More than 25% but not more than 50% → OE
    CIF 4 - Ownership of shares – More than 25% but not more than 50% → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.